Levy Adam D. — SEC Form 4 filings

SEC reporting owner CIK 2061876. 6 Form 4 filings on record with FilingPulse; latest filed 2026-08-06.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2025-04-03 to 2026-08-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Acrivon Therapeutics, Inc. (ACRV)Chief Financial Officer61 leg · 8,832 sh · $14,9991 leg · 1,142 sh · $1,7934

Form 4 filings — Levy Adam D.

FiledFormIssuerReported transactionsSource
2026-08-064Acrivon Therapeutics, Inc. (ACRV)Sale (S): 1,142 @ $1.57EDGAR
2026-05-204Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 46,167 @ $0EDGAR
2026-03-034Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 132,925 (derivative) @ $0EDGAR
2026-01-164Acrivon Therapeutics, Inc. (ACRV)Purchase (P): 8,832 @ $1.70EDGAR
2025-08-054Acrivon Therapeutics, Inc. (ACRV)Tax withholding (F): 1,164 @ $1.26EDGAR
2025-04-034Acrivon Therapeutics, Inc. (ACRV)Grant/award (A): 35,209 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2061876 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →